BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2008
View Archived Issues
Preclinical studies reveal biodistribution and safety profile for NSC-715818
Read More
Further data on tubulin inhibitor LP-261 available
Read More
Progress seen in development of MEK inhibitors from Ardea Biosciences
Read More
DMS-3008 tested against lung, head and neck cancer in vitro and in vivo
Read More
Cell sensitization with KU-0060648 improves DNA damaging anticancer therapy
Read More
Novel antiangiogenic alphavbeta3 integrin antagonists developed at Allergan
Read More
Anesiva expands European license agreement for Zingo with Sigma-Tau
Read More
NCI initiates phase I trial of Dusa's Levulan PDT in oral precancerous lesions
Read More
Proteolix initiates phase II clinical trial of carfilzomib for relapsed solid tumors
Read More
Roche exercises option to further develop Memory's nicotinic alpha7 agonist MEM-3454
Read More
T-2384, a novel antidiabetic agent shows good results in preclinical studies
Read More
Amgen presents a novel c-Met inhibitor with antitumor activity in vivo
Read More
Elan outlines advances of first quarter
Read More
FDA advisory committee recommends approval of Cinryze for HAE
Read More
Febuxostat receives E.U. marketing authorization for hyperuricemia in gout
Read More
Protez commences phase II clinical study for PZ-601 in infectious diseases
Read More
Novel antiinfective agents disclosed in recent patents
Read More
Emergent BioSolutions acquires rPA-102 anthrax vaccine from VaxGen for USD 2 million
Read More
NicOx presents phase II results for PF-03187207 in glaucoma and ocular hypertension
Read More
New analgesic agents described in recent Xenon patents
Read More
N30 Pharma completes phase I clinical studies with N30-201
Read More
Recent Abbott and Merck patents report new compounds for Alzheimer's disease
Read More
Can-Fite successfully completes phase I CF-102 trial
Read More
Cell Therapeutics changes brand name of Xyotax to Opaxio
Read More
Health Canada accepts for review Basilea's NDA for alitretinoin in chronic hand eczema
Read More
GlaxoSmithKline initiates tender offer to acquire Sirtris Pharmaceuticals
Read More